Featured Research

from universities, journals, and other organizations

By Combining Technologies, Researchers Rapidly Hunt Down And Find New Genes That Lead To Cancer

Date:
November 14, 2008
Source:
Cell Press
Summary:
Using a new approach that combines scientific technologies to hunt down genetic changes involved in cancer, researchers have discovered 13 tumor suppressor genes that, when mutated, can lead to liver cancers. Twelve of those genes had never been linked to cancer before, according to a new study.

Using a new approach that combines scientific technologies to hunt down genetic changes involved in cancer, researchers have discovered 13 tumor suppressor genes that, when mutated, can lead to liver cancers. Twelve of those genes had never been linked to cancer before, according to the report published online in the journal Cell, a Cell Press publication, on November 13th.

Related Articles


"It's important to understand all the genetic alterations that can give rise to cancer," said Howard Hughes Medical Institute Investigator Scott Lowe of Cold Spring Harbor Laboratory. "If we understand cancer, we can treat it better by going after the molecular causes or by categorizing cancers to better predict their behavior."

One of the challenges in identifying those mutations that are responsible for causing cancer is that, as Lowe puts it, cancers are often a mess. In other words, a given cancer may contain many mutations, some that drive the cancer and others that are just along for the ride. The challenge then is to sift through all the changes found in cancer to identify those that are functionally relevant to the disease.

Recent efforts to catalogue the cancer genome—all the genes that can play a role in cancer—have been stimulated by advances in genomics, Lowe said. But a genomic approach on its own can only identify genes that are, statistically speaking, more often altered, lost or amplified, in cancer than they are in non-cancer. It doesn't tell you what those genes do.

In the new study, the researchers first identified genes that were recurrently deleted in 100 human liver cancers. The notion was that genes frequently lost in cancer likely include tumor suppressors that normally keep cancer at bay. That effort turned up 58 deletions, each including one to 46 genes, for a total of 362 genes.

They then identified mouse versions of 301 of those human genes and obtained so-called short hairpin RNAs (shRNA) corresponding to each of those. shRNA is a sequence of RNA that makes a tight hairpin turn and that can be used to silence genes in a process known as RNA interference. Those shRNAs were used to silence the cancer-linked genes one by one in liver progenitor cells that were then transplanted back into mice.

The mice they studied already had genetic changes known to occur in liver cancer but that aren't enough on their own to produce the disease. The idea, Lowe said, was to see which of the genes lost in human cancers could push those mice over the edge and into tumor development.

Their strategy quickly led them to 13 genes that, when silenced, could lead to cancer, most of them completely new. "Some of the genes make sense and suggest straightforward ways to follow up," Lowe said. "Others are completely unknown."

In fact, that's one of the big advantages of the new approach. It makes very few assumptions about the kinds of genes that are likely to play a role in cancer. "It allows the opportunity to tap into new and unappreciated areas of cancer biology we never would have looked at," he said.

The gene discoveries already suggest some possible new avenues to cancer therapy.

Indeed, two of the new tumor suppressors they identified represent secreted proteins. That may be good news in a practical sense since treatments designed to deliver those proteins systemically may hold promise for therapy.

" It's hard to put a gene back, but if it's a secreted protein, in theory you could inject the protein back," he said. They haven't yet validated that idea, but it's something he says his team intends to follow up on.

One of the other genes they found called XPO4, which encodes a nuclear export protein, may sensitize cells to drugs known as SMAD3 inhibitors that are now in clinical trials, they said. Since XPO4 loss is associated with poor survival in breast cancer patients, they noted that agents targeting this pathway may turn out to be clinically important.

The genes they uncovered also turned up a surprise, Lowe said. While most scientists imagine that deletion of a region containing multiple genes will have just one gene with relevance to cancer, they found multiple instances in which more than one gene within a deleted region can lead to cancer.

" Apparently, there is a high incidence of cancer genes that are physically next to each other in the genome," he said. The findings also show that there are just a lot of genes that can cause cancer. "It may explain why cancer is so heterogeneous; there are a lot of possible combinations to get there."

The same approach applied here to liver cancer can be applied to other forms of cancer, including leukemias, lymphomas, breast and some brain cancers, Lowe said. They also suspect that there will be more to find in the case of liver cancer.

The researchers include Lars Zender, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY; Wen Xue, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY; Johannes Zuber, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY; Camile P. Semighini, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY; Alexander Krasnitz, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY; Beicong Ma, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY; Peggy Zender, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY; Stefan Kubicka, Medical School Hannover, Hannover, Germany; John M. Luk, University of Hong Kong, Hong Kong, China; Peter Schirmacher, University Hospital Heidelberg, Heidelberg, Germany; Richard W. McCombie, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY; Michael Wigler, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY; James Hicks, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY; Gregory J. Hannon, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY, Howard Hughes Medical Institute, Cold Spring Harbor, New York, NY; Scott Powers, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY; and Scott W. Lowe, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY, Howard Hughes Medical Institute, Cold Spring Harbor, New York, NY.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Cite This Page:

Cell Press. "By Combining Technologies, Researchers Rapidly Hunt Down And Find New Genes That Lead To Cancer." ScienceDaily. ScienceDaily, 14 November 2008. <www.sciencedaily.com/releases/2008/11/081113140308.htm>.
Cell Press. (2008, November 14). By Combining Technologies, Researchers Rapidly Hunt Down And Find New Genes That Lead To Cancer. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2008/11/081113140308.htm
Cell Press. "By Combining Technologies, Researchers Rapidly Hunt Down And Find New Genes That Lead To Cancer." ScienceDaily. www.sciencedaily.com/releases/2008/11/081113140308.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins